Regulators in the European Union aren’t impressed with Provigil as a multipurpose wakefulness remedy. The European Medicines Agency has recommended new restrictions on the use of the Cephalon drug. Provigil should be used only to treat narcolepsy, the regulators say, because the benefits for other indications may not be…
The Federal Trade Commission is fighting back against allegations that it overstepped its bounds in investigating a “pay-for-delay” deal between Cephalon ( NASDAQ: CEPH ) and Watson Pharmceuticals ( NYSE: WPI ). The agency not only denied that it shared confidential information on Watson with generic rival Apotex, it’s…
The Roche Group posted strong operating results in the first half of 2010. Group sales grew by 5% in local currencies (3% in Swiss francs; 7% in US dollars) to 24.6 billion Swiss francs. The Pharmaceuticals Division increased its sales by 4% in local currencies (1% in Swiss francs; 6%…
As part of its commitment to improving the quality of patient care, Pfizer (NYSE: PFE) will make available assessment scales used by physicians and others in the healthcare community to support the evaluation and diagnosis of patients suffering from certain mental disorders.
Original Source of Pfizer to Offer Free Public…
Bristol-Myers Squibb Company (NYSE: BMY) reported results for the second quarter of 2010 which featured data on key marketed and investigational compounds in its oncology, diabetes and cardiovascular franchises, and growth in sales and EPS.
Original Source of Bristol-Myers Squibb Second Quarter Featured Robust Clinical Data and Double-Digit EPS Growth…
One of the themes emerging from this round of pharma earnings reports is Europe–specifically,
According to a congressional probe, Chinese officials sandbagged an investigation into the contaminated heparin linked to 81 deaths in late 2007 and early 2008. Texas Republicans Reps. Joe Barton and Michael Burgess say FDA officials have been “severely hampered” by China’s foot-dragging in tracing the contamination to its ultimate…
What’s a drugmaker to do when its lead product falls off the patent cliff? If you’re Eisai , you move manufacturing to India. The company plans to shift production of its Alzheimer’s drug Aricept to the subcontinent in the first such move by a Japanese pharma company, Reuters reports….
Want a prestigious speaker to talk about your drugs? Forget anyone from Harvard Medical School. The
GlaxoSmithKline ( NYSE: GSK )